Journal Article

Inhibition of human lung cancer cell growth by angiotensin-(1-7)

Patricia E. Gallagher and E.Ann Tallant

in Carcinogenesis

Volume 25, issue 11, pages 2045-2052
Published in print November 2004 | ISSN: 0143-3334
Published online November 2004 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgh236
Inhibition of human lung cancer cell growth by angiotensin-(1-7)

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Angiotensin-(1-7) [Ang-(1-7)] is an endogenous peptide hormone of the renin–angiotensin system with vasodilator and anti-proliferative properties. Human adenocarcinoma SK-LU-1 and A549 cells as well as non-small lung cancer SK-MES-1 cells were treated with serum in the presence and absence of Ang-(1-7), to determine whether Ang-(1-7) inhibits the growth of lung cancer cells. Ang-(1-7) caused a significant reduction in serum-stimulated growth in all three lung cancer cell lines. Treatment with Ang-(1-7) resulted in both a dose- and time-dependent reduction in serum-stimulated DNA synthesis in all three cell lines, with IC50's in the sub-nanomolar range. The Ang-(1-7) receptor antagonist [d-Ala7]-Ang-(1-7) blocked the attenuation of the serum-stimulated DNA synthesis of SK-LU-1 cells by Ang-(1-7), while neither AT1 nor AT2 angiotensin receptor subtype antagonists prevented the response to the heptapeptide. MAS mRNA and protein, a receptor for Ang-(1-7), was detected in the three lung cancer cell lines, suggesting that the anti-proliferative effect of Ang-(1-7) in the cancer cells may be mediated by the non-AT1, non-AT2, AT(1-7) receptor MAS. Other angiotensin peptides [Ang I, Ang II, Ang-(2-8), Ang-(3-8) and Ang-(3-7)] did not attenuate mitogen-stimulated DNA synthesis of SK-LU-1 cells, demonstrating that Ang-(1-7) selectively inhibits SK-LU-1 cancer cell growth. Pre-treatment of SK-LU-1 cells with 10 nM Ang-(1-7) reduced serum-stimulated phosphorylation of extracellular signal-regulated kinase (ERK)1 and ERK2, indicating that the anti-proliferative effects may occur, at least in part, through inhibition of the ERK signal transduction pathway. The results of this study suggest that Ang-(1-7) inhibits lung cancer cell growth through the activation of an angiotensin peptide receptor and may represent a novel chemotherapeutic and chemopreventive treatment for lung cancer.

Keywords: ACE, angiotensin-converting enzyme; ACE2, angiotensin-converting enzyme 2; Ang I, angiotensin I; Ang II, angiotensin II; Ang-(1-7), angiotensin-(1-7); [d-Ala7]-Ang-(1-7), [d-alanine7]-angiotensin-(1-7); EGF, epidermal growth factor; ERK, extracellular signal-regulated kinase; FBS, fetal bovine serum; MAP, mitogen-activated protein; PBS, phosphate-buffered saline; VSMC, vascular smooth muscle cells

Journal Article.  6471 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.